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cancers SOD2 expression is partially controlled epigenetically
and our future work will determine the mechanism of repression
of the gene in OA chondrocytes.
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EXPRESSION OF ANK (progressive ankylosis) IS
SENSITVE TO OXYGEN
R. Zaka, A.S. Dion, A. Kusnierz, J. Bohensky, V. Srinivas,
C.J. Williams
Thomas Jefferson University, Philadelphia, PA
Purpose: The proximal promoter region of Ank, a gene that
codes for a transmembrane protein that regulates the transport
of inorganic pyrophosphate, contains a hypoxia responsive ele-
ment (HRE). These studies were undertaken to investigate the
expression and function of Ank in response to varying oxygen
tensions.
Methods: ATDC5 and N1511 clonal chondrocytic cell lines were
subjected to culture in either hypoxic (2% O2) or normoxic (21%
O2) conditions for 24 and 48 hours. Transcript levels of Ank were
determined using real time PCR and protein levels were evalu-
ated by Western blot analyses. As control, levels of expression of
the hypoxia inducible factor 1 (HIF-1)- regulated transcript Vegf
were simultaneously evaluated under varying oxygen tensions.
Transcript stability at the two oxygen tensions was determined
by treatment of cells with the transcription inhibitor α-amanitin.
N1511 cells were also subjected to differentiation with the addi-
tion of BMP2 and the effect of varying oxygen tensions on the
cells at hypertrophy was investigated. To determine the possible
role of HIF-1 in the observed hypoxic response, N1511 cells in
which Hif-1α was knocked down were exposed to varying oxy-
gen conditions and levels of Ank expression were determined.
Finally, the effect of varying oxygen tensions on the elaboration
of extracellular pyrophosphate in ATDC5 cells was explored.
Results: At 24 and 48 hours, a relative fourfold and eight-fold
increase, respectively, in Ank mRNA expression was observed
at high oxygen tension in both cell lines. To exclude the possi-
bility that these results were due to differential stability of Ank
mRNA in normoxic vs. hypoxic conditions, steady-state levels
of mRNA expression were explored after treating ATDC5 cells
with α-amanitin. No signiﬁcant differences in the decay of Ank
mRNA levels in hypoxia vs. normoxia were observed over a
period of 40 hours in the presence of α-amanitin. To deter-
mine if the oxemic response was conserved when N1511 cells
were differentiated, BMP2-treated cells at day 5 of differentiation
(hypertrophy) were exposed to varying oxygen tensions and a
similar relative increase in the expression of Ank mRNA was
observed in normoxia, with concomitant increase in Ank protein
levels as determined by Western blot analyses. When N1511
cells in which Hif-1α was knocked down by siRNA were sub-
jected to varying oxygen tensions, the relative expression of Ank
mRNA in normoxic conditions was dramatically reduced, sug-
gesting that the oxemic regulation of Ank expression is mediated
by HIF-1. Finally, consistent with the relative increase in Ank
expression in normoxia after 24 hours, levels of extracellular py-
rophosphate were also increased in normoxia in the ATDC5 cell
line.
Conclusions: These data suggest that Ank expression is up-
regulated in normoxic environments and that the up-regulation
is not due to differential mRNA stability. The results further
suggest that the observed effect is regulated by Hif-1α, the
oxygen responsive subunit of HIF-1, and that the oxemic re-
sponse also affects the pyrophosphate transport activity of Ank.
Although many transcripts respond to oxygen by up-regulating
their expression at low oxygen tensions, there are several ex-
amples of transcripts whose expression is down-regulated at
low oxygen tensions, including α-fetoprotein and heme 1 oxy-
genase. The general mechanism of hypoxia repression often
involves the elaboration of a negative response element that
mediates transcriptional activation by HIF-1. Future studies will
explore such a mechanism in the oxemic control of Ank expres-
sion.
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PPARγ1 EXPRESSION IS DIMINISHED IN HUMAN OA
CARTILAGE AND IS DOWN-REGULATED BY IL-1β IN
ARTICULAR CHONDROCYTES
N. Chabane, N. Zayed, M. Benderdour, J. Martel-Pelletier,
J-P. Pelletier, H. Fahmi
University of Montreal, Montreal, PQ, Canada
Purpose: Peroxisome proliferator-activated receptor γ (PPARγ)
is a nuclear receptor involved in the regulation of many cellular
processes. We and others have previously shown that PPARγ ac-
tivators display anti-inﬂammatory and chondroprotective proper-
ties in vitro and improve the clinical course and histopathological
features in an experimental animal model of osteoarthritis (OA).
However, the expression and regulation of PPARγ in cartilage
are poorly deﬁned. This study was undertaken to investigate the
quantitative expression and distribution of PPARγ in normal and
OA cartilage and to evaluate the effect of interleukin-1β (IL-1),
a prominent cytokine in OA, on PPARγ expression in cultured
chondrocytes.
Methods: Expression of PPARγ protein and mRNA in cartilage
were determined by immunohistochemistry and quantitative real-
time reverse transcription-polymerase chain reaction (RT-PCR),
respectively. Cultured chondrocytes were stimulated with IL-1
alone or in combination with selective inhibitors of signal trans-
duction pathways, and PPARγ1 expression was analyzed by
Western blot. Activation of the PPARγ1 promoter was assessed
in transient transfection experiments.
Results: Immunohistochemical analysis revealed that the lev-
els of PPARγ protein expression were signiﬁcantly lower in
OA cartilage compared to normal cartilage. Using RT-PCR, we
demonstrated that PPARγ1 mRNA levels were ∼10-fold higher
than PPARγ2 mRNA levels; and that only PPARγ1 was differen-
tially expressed, its levels in OA cartilage being 2.4-fold lower
than in normal cartilage (P<0.001). IL-1 treatment of OA chon-
drocytes down-regulated PPARγ1 expression in a dose- and
time-dependent manner. This effect probably occurred at the
transcriptional level, since IL-1 decreases both PPARγ1 mRNA
expression and PPARγ1 promoter activity. Tumor necrosis factor
(TNF-α), IL-17, and prostaglandin E2 (PGE2), which are involved
in the pathogenesis of OA, also down-regulated PPARγ1 expres-
sion. Speciﬁc inhibitors of the mitogen-activated protein kinase
(MAPK) p38 (SB203580) and JNK (SP600125), but not Erk
(PD98059) prevented IL-1-induced down-regulation of PPARγ1
expression. Similarly, inhibitors of NF-κB signaling (PDTC, MG-
132, and SN-50) abolished the suppressive effect of IL-1.
Conclusions: Our study has demonstrated for the ﬁrst time that
PPARγ1 is down-regulated in OA cartilage. The pro-inﬂammatory
cytokine IL-1 may be responsible for this down-regulation via a
mechanism involving activation of the MAPKs (p38 and JNK) and
NF-κB signaling pathways. The IL-1-induced down-regulation
of PPARγ expression may be an important new process by
which IL-1 promotes articular inﬂammation and cartilage degra-
dation.
